IMODIUM

This brand name is authorized in Austria, Canada, Cyprus, Germany, Estonia, Finland, France, Hong Kong, Croatia, Ireland, Israel, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, United Kingdom, South Africa

Active ingredients

The drug IMODIUM contains one active pharmaceutical ingredient (API):

1 Loperamide UNII 77TI35393C - LOPERAMIDE HYDROCHLORIDE

By binding to opiate receptors in the gut wall, loperamide hydrochloride reduces propulsive peristalsis, increases intestinal transit time and enhances resorption of water and electrolytes. Loperamide increases the tone of the anal sphincter, which helps reduce faecal incontinence and urgency. Read about Loperamide

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
IMODIUM Capsule	Health Products Regulatory Authority (IE)	MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
A07DA03	Loperamide	A Alimentary tract and metabolism → A07 Antidiarrheals, intestinal antiinflammatory/antiinfective agents → A07D Antipropulsives → A07DA Antipropulsives
Discover more medicines within A07DA03

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: CA	Health Products and Food Branch	Identifier(s): 02230542, 02291800, 02376016
Country: DE	Bundesinstitut für Arzneimittel und Medizinprodukte	Identifier(s): 00141551, 01689848, 01689854, 01869444, 02334188, 03829609, 04638834, 04910153, 04910176, 04940757, 07296788, 07299261, 07370740, 07374293, 07606533
Country: EE	Ravimiamet	Identifier(s): 1008997, 1063482, 1603651, 1603662, 1603673
Country: FI	Lääkealan turvallisuus- ja kehittämiskeskus	Identifier(s): 037669, 080755, 497499, 569277, 569285
Country: FR	Base de données publique des médicaments	Identifier(s): 60095095, 61203061, 61651634, 65272215, 69522794
Country: GB	Medicines & Healthcare Products Regulatory Agency	Identifier(s): 18234, 185535, 185536, 19243, 279804, 279805, 289618, 299082, 299083, 81424
Country: HK	Department of Health Drug Office	Identifier(s): 46489
Country: HR	Agencija za lijekove i medicinske proizvode	Identifier(s): HR-H-493726499
Country: IE	Health Products Regulatory Authority	Identifier(s): 28681, 28706
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 3220
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1008165, 1015752, 1022765, 1068119, 1069908, 1076666
Country: MT	Medicines Authority	Identifier(s): AA565/73301, AA908/06503, MA1471/00301, PI521/01801C, PI908/06501A
Country: MX	Comisión Federal para la Protección contra Riesgos Sanitarios	Identifier(s): 83335
Country: NL	Z-Index G-Standaard	Identifier(s): 12310700
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 15695, 3212, 85391
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 11324, 14818, 15626, 15627
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100105204
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W64913001, W64913002, W65625001, W65625002, W65625003, W65625004
Country: SG	Health Sciences Authority	Identifier(s): 06212P
Country: ZA	Health Products Regulatory Authority	Identifier(s): 29/11.9/0213, H/11.9/152, J/11.9/166, U/11.9/213